O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	17	the	the	B-NP	DT	O	7	NMOD	O
O	O	18	32	megakaryocytic	megakaryocytic	I-NP	JJ	B-DNA	7	NMOD	B-DNA
T1	B-Protein	33	45	glycoprotein	glycoprotein	I-NP	NN	I-DNA	7	NMOD	I-DNA
T1	I-Protein	46	48	IX	IX	I-NP	CD	I-DNA	7	NMOD	I-DNA
T21	B-Entity	49	57	promoter	promoter	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	58	60	by	by	B-PP	IN	O	1	NMOD	O
O	O	61	64	the	the	B-NP	DT	O	13	NMOD	O
O	O	65	74	oncogenic	oncogenic	I-NP	JJ	B-protein	13	NMOD	B-protein
O	O	75	78	Ets	Ets	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	79	92	transcription	transcription	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	93	99	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
T2	B-Protein	100	103	Fli	Fli	O	AFX	B-protein	15	NMOD	B-protein
T2	I-Protein	103	104	-	-	B-NP	HYPH	I-protein	8	PMOD	I-protein
T2	I-Protein	104	105	1	1	I-NP	CD	I-protein	15	NMOD	I-protein
O	O	105	106	.	.	O	.	O	1	P	O

T3	B-Protein	108	120	Glycoprotein	Glycoprotein	B-NP	NN	B-protein	3	NMOD	B-protein
T3	I-Protein	121	122	(	(	O	(	I-protein	3	NMOD	I-protein
T3	I-Protein	122	124	GP	GP	B-NP	NN	I-protein	6	SUB	I-protein
T3	I-Protein	124	125	)	)	O	)	I-protein	3	NMOD	I-protein
T3	I-Protein	126	128	IX	IX	B-NP	CD	I-protein	3	NMOD	I-protein
O	O	129	131	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	132	133	a	a	B-NP	DT	O	8	NMOD	O
O	O	134	141	subunit	subunit	I-NP	NN	O	15	NMOD	O
O	O	142	144	of	of	B-PP	IN	O	8	NMOD	O
O	O	145	148	the	the	B-NP	DT	O	13	NMOD	O
T22	B-Entity	149	152	von	von	I-NP	NN	B-protein	13	NMOD	B-protein
T22	I-Entity	153	163	Willebrand	Willebrand	I-NP	NN	I-protein	13	NMOD	I-protein
T22	I-Entity	164	172	receptor	receptor	I-NP	NN	I-protein	9	PMOD	I-protein
O	O	172	173	,	,	O	,	O	15	P	O
T23	B-Entity	174	178	GPIb	GPIb	B-NP	NN	B-protein	18	NMOD	B-protein
T23	I-Entity	178	179	-	-	B-NP	HYPH	O	18	P	O
T23	I-Entity	179	180	V	V	I-NP	NN	B-protein	18	NMOD	B-protein
T23	I-Entity	180	181	-	-	B-NP	HYPH	I-protein	6	P	I-protein
T23	I-Entity	181	183	IX	IX	I-NP	CD	I-protein	6	PRD	I-protein
O	O	183	184	,	,	O	,	O	19	P	O
O	O	185	190	which	which	B-NP	WDT	O	19	NMOD	O
O	O	191	199	mediates	mediate	B-VP	VBZ	O	21	SBAR	O
O	O	200	208	adhesion	adhesion	B-NP	NN	O	22	OBJ	O
O	O	209	211	of	of	B-PP	IN	O	23	NMOD	O
O	O	212	221	platelets	platelet	B-NP	NNS	B-cell_type	24	PMOD	B-cell_type
O	O	222	224	to	to	B-PP	TO	O	23	NMOD	O
O	O	225	228	the	the	B-NP	DT	O	28	NMOD	O
O	O	229	243	subendothelium	subendothelium	I-NP	NN	O	26	PMOD	O
O	O	244	246	of	of	B-PP	IN	O	28	NMOD	O
O	O	247	254	damaged	damage	B-NP	VBN	O	32	NMOD	O
O	O	255	260	blood	blood	I-NP	NN	O	32	NMOD	O
O	O	261	268	vessels	vessel	I-NP	NNS	O	29	PMOD	O
O	O	268	269	.	.	O	.	O	6	P	O

O	O	270	278	Previous	Previous	B-NP	JJ	O	2	NMOD	O
O	O	279	295	characterization	characterization	I-NP	NN	O	7	SUB	O
O	O	296	298	of	of	B-PP	IN	O	2	NMOD	O
O	O	299	302	the	the	B-NP	DT	O	6	NMOD	O
T4	B-Protein	303	307	GPIX	GPIX	I-NP	NN	B-DNA	6	NMOD	B-DNA
T24	B-Entity	308	316	promoter	promoter	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	317	327	identified	identify	B-VP	VBD	O	0	ROOT	O
O	O	328	329	a	a	B-NP	DT	O	11	NMOD	O
O	O	330	340	functional	functional	I-NP	JJ	O	11	NMOD	O
T25	B-Entity	341	344	Ets	Ets	I-NP	NN	B-DNA	11	NMOD	B-DNA
T25	I-Entity	345	349	site	site	I-NP	NN	I-DNA	7	OBJ	I-DNA
O	O	350	354	that	that	B-NP	WDT	O	11	NMOD	O
O	O	354	355	,	,	O	,	O	12	P	O
O	O	356	360	when	when	B-ADVP	WRB	O	17	VMOD	O
O	O	361	370	disrupted	disrupt	B-VP	VBN	O	14	SBAR	O
O	O	370	371	,	,	O	,	O	17	P	O
O	O	372	379	reduced	reduce	B-NP	VBN	O	12	SBAR	O
O	O	380	388	promoter	promoter	I-NP	NN	O	19	NMOD	O
O	O	389	397	activity	activity	I-NP	NN	O	17	OBJ	O
O	O	397	398	.	.	O	.	O	7	P	O

O	O	399	406	However	However	B-ADVP	RB	O	14	VMOD	O
O	O	406	407	,	,	O	,	O	14	P	O
O	O	408	411	the	the	B-NP	DT	O	7	NMOD	O
O	O	412	415	Ets	Ets	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	416	423	protein	protein	I-NP	NN	I-protein	7	NMOD	I-protein
O	O	423	424	(	(	I-NP	(	O	7	NMOD	O
O	O	424	425	s	s	I-NP	NNS	O	14	SUB	O
O	O	425	426	)	)	O	)	O	7	NMOD	O
O	O	427	431	that	that	B-NP	WDT	O	7	NMOD	O
O	O	432	441	regulated	regulate	B-VP	VBD	O	9	SBAR	O
T5	B-Protein	442	446	GPIX	GPIX	B-NP	NN	B-DNA	13	NMOD	B-DNA
T26	B-Entity	447	455	promoter	promoter	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	456	466	expression	expression	I-NP	NN	O	10	OBJ	O
O	O	467	470	was	be	B-VP	VBD	O	0	ROOT	O
O	O	471	478	unknown	unknown	B-ADJP	JJ	O	14	PRD	O
O	O	478	479	.	.	O	.	O	14	P	O

O	O	480	482	In	In	B-PP	IN	O	25	VMOD	O
O	O	483	487	this	this	B-NP	DT	O	3	NMOD	O
O	O	488	493	study	study	I-NP	NN	O	1	PMOD	O
O	O	493	494	,	,	O	,	O	25	P	O
O	O	495	504	transient	transient	B-NP	JJ	O	6	NMOD	O
O	O	505	519	cotransfection	cotransfection	I-NP	NN	O	25	SUB	O
O	O	520	522	of	of	B-PP	IN	O	6	NMOD	O
O	O	523	530	several	several	B-NP	JJ	O	7	PMOD	O
T6	B-Protein	531	535	GPIX	GPIX	I-NP	NN	B-DNA	10	NMOD	B-DNA
T27	B-Entity	536	544	promoter	promoter	I-NP	NN	I-DNA	8	NMOD	I-DNA
O	O	544	545	/	/	B-VP	SYM	O	8	NMOD	O
O	O	545	553	reporter	reporter	B-NP	NN	B-DNA	13	NMOD	B-DNA
O	O	554	564	constructs	construct	I-NP	NNS	I-DNA	11	OBJ	I-DNA
O	O	565	569	into	into	B-PP	IN	O	11	VMOD	O
O	O	570	574	293T	293T	B-NP	NN	B-cell_line	17	NMOD	B-cell_line
O	O	575	581	kidney	kidney	I-NP	NN	I-cell_line	17	NMOD	I-cell_line
O	O	582	593	fibroblasts	fibroblast	I-NP	NNS	I-cell_line	14	PMOD	I-cell_line
O	O	594	598	with	with	B-PP	IN	O	17	NMOD	O
O	O	599	600	a	a	B-NP	DT	O	24	NMOD	O
T7	B-Protein	601	604	Fli	Fli	I-NP	NNP	O	24	NMOD	O
T7	I-Protein	604	605	-	-	I-NP	HYPH	B-DNA	24	NMOD	B-DNA
T7	I-Protein	605	606	1	1	I-NP	CD	I-DNA	24	NMOD	I-DNA
T28	B-Entity	607	617	expression	expression	I-NP	NN	I-DNA	24	NMOD	I-DNA
T28	I-Entity	618	624	vector	vector	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	625	630	shows	show	B-VP	VBZ	O	0	ROOT	O
O	O	631	635	that	that	B-SBAR	IN	O	25	VMOD	O
O	O	636	639	the	the	B-NP	DT	O	29	NMOD	O
O	O	640	649	oncogenic	oncogenic	I-NP	JJ	B-protein	29	NMOD	B-protein
O	O	650	657	protein	protein	I-NP	NN	I-protein	31	NMOD	I-protein
T8	B-Protein	658	661	Fli	Fli	I-NP	NNP	B-protein	31	NMOD	B-protein
T8	I-Protein	661	662	-	-	B-NP	HYPH	I-protein	33	SUB	I-protein
T8	I-Protein	662	663	1	1	I-NP	CD	I-protein	31	NMOD	I-protein
O	O	664	667	can	can	B-VP	MD	O	26	SBAR	O
O	O	668	681	transactivate	transactivate	I-VP	VB	O	33	VC	O
O	O	682	685	the	the	B-NP	DT	O	37	NMOD	O
T9	B-Protein	686	690	GPIX	GPIX	I-NP	NN	B-DNA	37	NMOD	B-DNA
T29	B-Entity	691	699	promoter	promoter	I-NP	NN	I-DNA	34	OBJ	I-DNA
O	O	700	704	when	when	B-ADVP	WRB	O	34	VMOD	O
O	O	705	707	an	an	B-NP	DT	O	43	NMOD	O
O	O	708	714	intact	intact	I-NP	JJ	O	43	NMOD	O
T10,T30	B-Protein,B-Entity	715	719	GPIX	GPIX	I-NP	NN	B-DNA	43	NMOD	B-DNA
T30	I-Entity	720	723	Ets	Ets	I-NP	NN	I-DNA	43	NMOD	I-DNA
T30	I-Entity	724	728	site	site	I-NP	NN	I-DNA	44	SUB	I-DNA
O	O	729	731	is	be	B-VP	VBZ	O	38	SBAR	O
O	O	732	739	present	present	B-ADJP	JJ	O	44	PRD	O
O	O	739	740	.	.	O	.	O	25	P	O

O	O	741	743	In	In	B-PP	IN	O	13	VMOD	O
O	O	744	752	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	752	753	,	,	O	,	O	13	P	O
T11	B-Protein	754	757	Fli	Fli	B-NP	NNP	B-protein	7	NMOD	B-protein
T11	I-Protein	757	758	-	-	I-NP	HYPH	I-protein	7	NMOD	I-protein
T11	I-Protein	758	759	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	760	767	binding	binding	I-NP	NN	O	13	SUB	O
O	O	768	770	of	of	B-PP	IN	O	7	NMOD	O
O	O	771	774	the	the	B-NP	DT	O	12	NMOD	O
T12,T31	B-Protein,B-Entity	775	779	GPIX	GPIX	I-NP	NN	B-DNA	12	NMOD	B-DNA
T31	I-Entity	780	783	Ets	Ets	I-NP	NN	I-DNA	12	NMOD	I-DNA
T31	I-Entity	784	788	site	site	I-NP	NN	I-DNA	8	PMOD	I-DNA
O	O	789	792	was	be	B-VP	VBD	O	0	ROOT	O
O	O	793	803	identified	identify	I-VP	VBN	O	13	VC	O
O	O	804	806	in	in	B-PP	IN	O	14	VMOD	O
O	O	807	815	antibody	antibody	B-NP	NN	O	18	NMOD	O
O	O	816	826	supershift	supershift	I-NP	NN	O	18	NMOD	O
O	O	827	838	experiments	experiment	I-NP	NNS	O	15	PMOD	O
O	O	839	841	in	in	B-PP	IN	O	18	NMOD	O
O	O	842	849	nuclear	nuclear	B-NP	JJ	O	21	NMOD	O
O	O	850	858	extracts	extract	I-NP	NNS	O	19	PMOD	O
O	O	859	866	derived	derive	B-VP	VBN	O	21	NMOD	O
O	O	867	871	from	from	B-PP	IN	O	22	VMOD	O
O	O	872	885	hematopoietic	hematopoietic	B-NP	JJ	B-cell_type	27	NMOD	B-cell_type
O	O	886	891	human	human	I-NP	JJ	I-cell_type	27	NMOD	I-cell_type
O	O	892	907	erythroleukemia	erythroleukemia	I-NP	NN	I-cell_type	27	NMOD	I-cell_type
O	O	908	913	cells	cell	I-NP	NNS	I-cell_type	23	PMOD	I-cell_type
O	O	913	914	.	.	O	.	O	13	P	O

O	O	915	926	Comparative	Comparative	B-NP	JJ	O	2	NMOD	O
O	O	927	934	studies	study	I-NP	NNS	O	3	SUB	O
O	O	935	941	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	942	946	that	that	B-SBAR	IN	O	3	VMOD	O
T13	B-Protein	947	950	Fli	Fli	B-NP	NNP	B-protein	6	NMOD	B-protein
T13	I-Protein	950	951	-	-	B-NP	HYPH	I-protein	8	SUB	I-protein
T13	I-Protein	951	952	1	1	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	953	956	was	be	B-VP	VBD	O	4	SBAR	O
O	O	957	961	also	also	B-ADVP	RB	O	8	VMOD	O
O	O	962	966	able	able	B-ADJP	JJ	O	8	PRD	O
O	O	967	969	to	to	B-VP	TO	O	12	VMOD	O
O	O	970	983	transactivate	transactivate	I-VP	VB	O	10	AMOD	O
O	O	984	987	the	the	B-NP	DT	O	14	NMOD	O
T14	B-Protein	988	997	GPIbalpha	GPIbalpha	I-NP	NN	B-protein	12	OBJ	B-protein
O	O	998	1001	and	and	O	CC	O	12	VMOD	O
O	O	1001	1002	,	,	O	,	O	12	P	O
O	O	1003	1005	to	to	B-PP	TO	O	12	VMOD	O
O	O	1006	1007	a	a	B-NP	DT	O	20	NMOD	O
O	O	1008	1014	lesser	less	I-NP	JJR	O	20	NMOD	O
O	O	1015	1021	extent	extent	I-NP	NN	O	17	PMOD	O
O	O	1021	1022	,	,	O	,	O	8	P	O
O	O	1023	1026	the	the	B-NP	DT	O	24	NMOD	O
T15	B-Protein	1027	1032	GPIIb	GPIIb	I-NP	NN	B-DNA	24	NMOD	B-DNA
T32	B-Entity	1033	1041	promoter	promoter	I-NP	NN	I-DNA	8	PRD	I-DNA
O	O	1041	1042	.	.	O	.	O	3	P	O

O	O	1043	1053	Immunoblot	Immunoblot	B-NP	NN	O	2	NMOD	O
O	O	1054	1062	analysis	analysis	I-NP	NN	O	3	SUB	O
O	O	1063	1073	identified	identify	B-VP	VBD	O	0	ROOT	O
T16	B-Protein	1074	1077	Fli	Fli	B-NP	NNP	B-protein	7	NMOD	B-protein
T16	I-Protein	1077	1078	-	-	B-NP	HYPH	I-protein	7	NMOD	I-protein
T16	I-Protein	1078	1079	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	1080	1087	protein	protein	I-NP	NN	I-protein	3	OBJ	I-protein
O	O	1088	1090	in	in	B-PP	IN	O	3	VMOD	O
O	O	1091	1098	lysates	lysate	B-NP	NNS	O	8	PMOD	O
O	O	1099	1106	derived	derive	B-VP	VBN	O	9	NMOD	O
O	O	1107	1111	from	from	B-PP	IN	O	10	VMOD	O
O	O	1112	1121	platelets	platelet	B-NP	NNS	B-cell_type	11	PMOD	B-cell_type
O	O	1121	1122	.	.	O	.	O	3	P	O

O	O	1123	1125	In	In	B-PP	IN	O	9	VMOD	O
O	O	1126	1134	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	1134	1135	,	,	O	,	O	9	P	O
O	O	1136	1146	expression	expression	B-NP	NN	O	9	SUB	O
O	O	1147	1149	of	of	B-PP	IN	O	4	NMOD	O
T17	B-Protein	1150	1153	Fli	Fli	B-NP	NNP	B-protein	7	NMOD	B-protein
T17	I-Protein	1153	1154	-	-	B-NP	HYPH	I-protein	5	PMOD	I-protein
T17	I-Protein	1154	1155	1	1	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	1156	1159	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1160	1170	identified	identify	I-VP	VBN	O	9	VC	O
O	O	1171	1192	immunohistochemically	immunohistochemically	B-ADVP	RB	O	10	VMOD	O
O	O	1193	1195	in	in	B-PP	IN	O	10	VMOD	O
O	O	1196	1210	megakaryocytes	megakaryocyte	B-NP	NNS	B-cell_type	12	PMOD	B-cell_type
O	O	1211	1218	derived	derive	B-VP	VBN	O	13	NMOD	O
O	O	1219	1223	from	from	B-PP	IN	O	14	VMOD	O
T18	B-Protein	1224	1228	CD34	CD34	B-NP	NN	B-cell_type	20	NMOD	B-cell_type
O	O	1228	1229	(	(	O	(	I-cell_type	19	DEP	I-cell_type
O	O	1229	1230	+	+	O	SYM	I-cell_type	19	DEP	I-cell_type
O	O	1230	1231	)	)	O	)	I-cell_type	16	NMOD	I-cell_type
O	O	1232	1237	cells	cell	B-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	1238	1245	treated	treat	B-VP	VBN	O	20	NMOD	O
O	O	1246	1250	with	with	B-PP	IN	O	21	VMOD	O
O	O	1251	1254	the	the	B-NP	DT	O	28	NMOD	O
O	O	1255	1268	megakaryocyte	megakaryocyte	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	1269	1284	differentiation	differentiation	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1285	1288	and	and	O	CC	I-protein	28	NMOD	I-protein
O	O	1289	1302	proliferation	proliferation	B-NP	NN	I-protein	28	NMOD	I-protein
O	O	1303	1309	factor	factor	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	1309	1310	,	,	O	,	O	30	P	O
T19	B-Protein	1311	1325	thrombopoietin	thrombopoietin	B-NP	NN	B-protein	22	PMOD	B-protein
O	O	1325	1326	.	.	O	.	O	9	P	O

O	O	1327	1332	These	These	B-NP	DT	O	2	NMOD	O
O	O	1333	1340	results	result	I-NP	NNS	O	3	SUB	O
O	O	1341	1348	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1349	1353	that	that	B-SBAR	IN	O	3	VMOD	O
T20	B-Protein	1354	1357	Fli	Fli	B-NP	NNP	B-protein	6	NMOD	B-protein
T20	I-Protein	1357	1358	-	-	B-NP	HYPH	I-protein	8	SUB	I-protein
T20	I-Protein	1358	1359	1	1	I-NP	CD	I-protein	6	NMOD	I-protein
O	O	1360	1362	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1363	1369	likely	likely	B-ADJP	JJ	O	8	PRD	O
O	O	1370	1372	to	to	B-VP	TO	O	11	VMOD	O
O	O	1373	1381	regulate	regulate	I-VP	VB	O	9	AMOD	O
T33	B-Entity	1382	1389	lineage	lineage	B-NP	NN	B-DNA	15	NMOD	B-DNA
T33	I-Entity	1389	1390	-	-	B-NP	HYPH	I-DNA	15	NMOD	I-DNA
T33	I-Entity	1390	1398	specific	specific	I-NP	JJ	I-DNA	15	NMOD	I-DNA
T33	I-Entity	1399	1404	genes	gene	I-NP	NNS	I-DNA	11	OBJ	I-DNA
O	O	1405	1411	during	during	B-PP	IN	O	11	VMOD	O
O	O	1412	1432	megakaryocytopoiesis	megakaryocytopoiesis	B-NP	NN	O	16	PMOD	O
O	O	1432	1433	.	.	O	.	O	3	P	O
